Appendix V - European Medicines Agency
List of details of the national reporting systems to communicate adverse reactions (side effects) for use in section 4.8 “Undesirable effects” of SmPC and section 4 “Possible side effects” of package leaflet. No reference to the Appendix V should be included in the printed packaging materials. ................
................
In order to avoid copyright disputes, this page is only a partial summary.
To fulfill the demand for quickly locating and searching documents.
It is intelligent file search solution for home and business.
Related download
- nia adverse event and serious adverse event guidelines
- template for reporting adverse events
- basic guidelines for potential investigators
- clinical research protocol
- australian regulatory guidelines for medical devices part
- guidelines for developing a manual of operations and
- appendix v european medicines agency
- ghtf sg2 comparison of the device adverse reporting
- recording management and reporting of adverse events
- investigator guidance prompt reporting requirements